Clovertex Awarded AWS Life Sciences Competency, Solidifying Leadership in Cloud-Based Solutions for Life Sciences

Achievement underscores expertise in cloud-driven advancements for drug discovery, genomics, clinical trials, and personalized medicine

BOSTON, Nov. 19, 2024 /PRNewswire/ — Clovertex is proud to announce its achievement of the prestigious AWS Life Sciences Competency, a recognition that highlights the company’s commitment to delivering innovative, cloud-based solutions for the life sciences sector. This milestone underscores Clovertex’s expertise in supporting critical areas such as drug discovery, genomics, clinical trials, and personalized medicine, helping to accelerate scientific discovery and advancements in healthcare.

The Amazon Web Services (AWS) Life Sciences Competency is awarded to organizations that demonstrate a deep understanding of the life sciences industry and the ability to provide solutions that address its unique challenges. Clovertex’s accomplishment reflects its dedication to leveraging AWS to streamline research and development processes, enhance data management, and enable collaboration among researchers and healthcare professionals.  In addition, Clovertex’s DevSecOps and Database Management services, delivered by teams experienced in GxP, are tailored for the life sciences industry.

“We are thrilled to receive the AWS Life Sciences Competency,” said Kshitij Kumar, Chief Executive Officer of Clovertex. “This recognition validates our efforts to harness cloud technology to drive innovation in the life sciences field. We remain committed to helping our clients navigate the complexities of research and development, and this competency enables us to further elevate our offerings.”

Through AWS’s robust infrastructure, Clovertex delivers scalable, secure solutions tailored to the evolving needs of the life sciences industry. The company’s solutions streamline workflows, optimize data handling, and foster collaboration, enabling research organizations to pursue groundbreaking discoveries with efficiency and reliability.

As a forward-looking organization, Clovertex is excited about the opportunities this competency presents and looks forward to continued collaboration with AWS and other industry leaders to advance the future of life sciences.

About Clovertex, Inc.
Clovertex, Inc. is a recognized leader in providing innovative solutions for the life sciences industry, dedicated to enhancing research and development through advanced technology and strategic partnerships. Clovertex’s mission is to empower life sciences organizations to achieve their research goals effectively and efficiently through cutting-edge cloud solutions.

For more information about Clovertex and its services, please visit clovertex.com or contact the team directly.

Media Contact:
Ben Pastro
Clovertex, Inc.
302-521-4959
386377@email4pr.com
clovertex.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/clovertex-awarded-aws-life-sciences-competency-solidifying-leadership-in-cloud-based-solutions-for-life-sciences-302309650.html

SOURCE Clovertex

Staff

Recent Posts

Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength

ST. PAUL, Minn., Dec. 16, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that it…

3 hours ago

2026 Brings Sharp 21% Spike in Health Insurance Premiums – Squeezing Household Budgets

ValuePenguin finds in 45 states, 2026 Health Insurance Premiums are Increasing by More Than 10%…

3 hours ago

Bioassay Method Transfer Strategies to Reduce Variability, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how to identify sources of variability in bioassay method transfers…

3 hours ago

Medical Device Validation Solutions for Evolving Industry Needs, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how medical devices benefit from modern digital validation strategies. Attendees…

3 hours ago

Leona Health Launches the World’s First AI Co‑Pilot for Doctors through WhatsApp

 Backed by $14M in seed funding led by Andreessen Horowitz, and pre-seed funding led by…

3 hours ago